How many institutions held CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share in Q4 2021?

115 institutional investors reported CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share for Q4 2021. Use the holders table for investor-level position and value details.

C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC)

Q: What does CUSIP 12529R107 represent in this 13F holders report?

CUSIP 12529R107 is the security identifier for CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 12529R107

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 88,353,400
Total 13F shares: 35,893,940
Share change: +688,260
Total reported value: $1,154,835,979
Price per share: $32.20
Number of holders: 115
Value change: +$16,687,200
Number of buys: 55
Number of sells: 47

Quarterly Holders Quick Answers

What is CUSIP 12529R107?
CUSIP 12529R107 identifies CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2022
Previous quarter: Q3 2021

Recent filing periods for CUSIP 12529R107:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

Top shareholders of CCCC - C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	4.5%	3,957,743	$176,832,000	—	30 Sep 2021	13F
BlackRock Finance, Inc.	13F	Company	3.6%	3,157,207	$141,064,000	—	30 Sep 2021	13F
RTW INVESTMENTS, LP	13F	Company	2.8%	2,494,965	$111,475,000	—	30 Sep 2021	13F
PERCEPTIVE ADVISORS LLC	13F	Company	2.6%	2,258,566	$100,913,000	—	30 Sep 2021	13F
VANGUARD GROUP INC	13F	Company	2.2%	1,938,575	$86,616,000	—	30 Sep 2021	13F
STATE STREET CORP	13F	Company	1.9%	1,658,630	$74,108,000	—	30 Sep 2021	13F
Bain Capital Life Sciences Investors, LLC	13F	Company	1.9%	1,642,209	$73,374,000	—	30 Sep 2021	13F
ArrowMark Colorado Holdings LLC	13F	Company	1.7%	1,514,620	$67,673,000	—	30 Sep 2021	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.6%	1,377,569	$61,550,000	—	30 Sep 2021	13F
WASATCH ADVISORS LP	13F	Company	1.5%	1,342,047	$59,963,000	—	30 Sep 2021	13F
PICTET ASSET MANAGEMENT SA	13F	Company	1.2%	1,098,421	$49,077,000	—	30 Sep 2021	13F
JANUS HENDERSON GROUP PLC	13F	Company	1.2%	1,048,888	$46,867,000	—	30 Sep 2021	13F
ADAGE CAPITAL PARTNERS GP, L.L.C.	13F	Company	0.92%	811,477	$36,257,000	—	30 Sep 2021	13F
Soleus Capital Management, L.P.	13F	Company	0.85%	750,633	$33,538,000	—	30 Sep 2021	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.75%	666,323	$29,771,000	—	30 Sep 2021	13F
Laurion Capital Management LP	13F	Company	0.75%	662,463	$29,599,000	—	30 Sep 2021	13F
FMR LLC	13F	Company	0.73%	648,981	$28,996,000	—	30 Sep 2021	13F
DRIEHAUS CAPITAL MANAGEMENT LLC	13F	Company	0.73%	641,399	$28,658,000	—	30 Sep 2021	13F
JENNISON ASSOCIATES LLC	13F	Company	0.55%	485,313	$21,684,000	—	30 Sep 2021	13F
Commodore Capital LP	13F	Company	0.54%	481,094	$21,495,000	—	30 Sep 2021	13F
Invesco Ltd.	13F	Company	0.53%	470,523	$21,023,000	—	30 Sep 2021	13F
UBS Group AG	13F	Company	0.47%	417,353	$18,647,000	—	30 Sep 2021	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.43%	381,774	$17,058,000	—	30 Sep 2021	13F
NORTHERN TRUST CORP	13F	Company	0.41%	363,953	$16,261,000	—	30 Sep 2021	13F
CLOUGH CAPITAL PARTNERS L P	13F	Company	0.39%	347,500	$15,526,000	—	30 Sep 2021	13F
Nuveen Asset Management, LLC	13F	Company	0.35%	307,336	$15,352,000	—	30 Sep 2021	13F
MORGAN STANLEY	13F	Company	0.33%	290,090	$12,961,000	—	30 Sep 2021	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.33%	287,573	$12,849,000	—	30 Sep 2021	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.3%	263,964	$11,794,000	—	30 Sep 2021	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.29%	260,452	$11,637,000	—	30 Sep 2021	13F
EcoR1 Capital, LLC	13F	Company	0.23%	200,000	$8,936,000	—	30 Sep 2021	13F
Point72 Asset Management, L.P.	13F	Company	0.23%	200,000	$8,936,000	—	30 Sep 2021	13F
Alyeska Investment Group, L.P.	13F	Company	0.14%	125,000	$5,585,000	—	30 Sep 2021	13F
Bank of New York Mellon Corp	13F	Company	0.13%	112,598	$5,031,000	—	30 Sep 2021	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.12%	105,314	$4,705,000	—	30 Sep 2021	13F
TD ASSET MANAGEMENT INC	13F	Company	0.11%	99,753	$4,457,000	—	30 Sep 2021	13F
FIRST TRUST ADVISORS LP	13F	Company	0.1%	86,952	$3,885,000	—	30 Sep 2021	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	0.09%	81,197	$3,628,000	—	30 Sep 2021	13F
Elena Prokupets	3/4/5	Director	— class O/S missing	534,807	$3,486,942	—	27 Sep 2021	3/4/5
CITIGROUP INC	13F	Company	0.08%	66,764	$2,983,000	—	30 Sep 2021	13F
Schonfeld Strategic Advisors LLC	13F	Company	0.07%	62,253	$2,782,000	—	30 Sep 2021	13F
Rafferty Asset Management, LLC	13F	Company	0.07%	59,051	$2,638,000	—	30 Sep 2021	13F
FEDERATED HERMES, INC.	13F	Company	0.07%	58,612	$2,619,000	—	30 Sep 2021	13F
JPMORGAN CHASE & CO	13F	Company	0.06%	54,829	$2,450,000	—	30 Sep 2021	13F
Bellevue Group AG	13F	Company	0.05%	47,200	$2,109,000	—	30 Sep 2021	13F
Eagle Health Investments LP	13F	Company	0.05%	47,200	$2,109,000	—	30 Sep 2021	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.05%	44,500	$1,988,000	—	30 Sep 2021	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.05%	43,415	$1,940,000	—	30 Sep 2021	13F
CITADEL ADVISORS LLC	13F	Company	0.05%	40,335	$1,802,000	—	30 Sep 2021	13F
P.A.W. CAPITAL CORP	13F	Company	0.05%	40,000	$1,787,000	—	30 Sep 2021	13F

Institutional Holders of C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) as of Q4 2021

As of 31 Dec 2021, C4 Therapeutics, Inc. - Common Stock, par value $0.0001 per share (CCCC) was held by 115 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 35,893,940 shares. The largest 10 holders included PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., RTW INVESTMENTS, LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, ArrowMark Colorado Holdings LLC, Bain Capital Life Sciences Investors, LLC, STATE STREET CORP, RA CAPITAL MANAGEMENT, L.P., and WASATCH ADVISORS INC. This page lists 116 institutional shareholders reporting positions in this security for the Q4 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2021 vs Q3 2021 Across Filers

Q3 2021 holders

110

Q4 2021 holders

115

Holder diff

Investor	Q3 2021 Shares	Q4 2021 Shares	Share Diff	Share Chg %	Q3 2021 Value $	Q4 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.